PDB45 EVALUATING THE SHORT-TERM COST-UTILITY OF INSULIN DEGLUDEC VERSUS INSULIN GLARGINE U100 IN BASAL-BOLUS REGIMENS FOR TYPE 2 DIABETES IN CHINA
| Autor: | Han, S., Shi, L.W., SUN, H.K., Dong, P.X., Zheng, L.Y. |
|---|---|
| Zdroj: | In Value in Health May 2019 22 Supplement 2:S147-S148 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect